|
|
|
Volumn 32, Issue 3, 2005, Pages 304-308
|
|
Multiple myeloma--recent advances in diagnosis and treatment
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
IMIDAZOLE DERIVATIVE;
PAMIDRONIC ACID;
PROTEINASE INHIBITOR;
PYRAZINE DERIVATIVE;
THALIDOMIDE;
ZOLEDRONIC ACID;
CANCER STAGING;
DOSE RESPONSE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
MULTIMODALITY CANCER THERAPY;
MULTIPLE MYELOMA;
PATHOLOGY;
REVIEW;
ANGIOGENESIS INHIBITORS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BORONIC ACIDS;
COMBINED MODALITY THERAPY;
DIPHOSPHONATES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMIDAZOLES;
MULTIPLE MYELOMA;
NEOPLASM STAGING;
PROTEASE INHIBITORS;
PYRAZINES;
THALIDOMIDE;
|
|
EID: 15544371473
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (19)
|
